Evidence map›Paper›PMID 36603053›Full record

ArticlePLoS biology2023

Identifying barriers and enablers to rigorous conduct and reporting of preclinical laboratory studies.

Manoj M Lalu, Justin Presseau, Madison K Foster, Victoria T Hunniford, Kelly D Cobey, Jamie C Brehaut, Carolina Ilkow, Joshua Montroy, Analyssa Cardenas, Ayni Sharif and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Building reproducible bridges to cross the "valley of death".The Journal of clinical investigation · 2024
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Manoj M LaluClinical Epidemiology Program, The Ottawa Hospital Research Institute; Ottawa, Ontario, Canada.ORCID 0000-0002-0322-382X
Justin PresseauClinical Epidemiology Program, The Ottawa Hospital Research Institute; Ottawa, Ontario, Canada.
Madison K FosterClinical Epidemiology Program, The Ottawa Hospital Research Institute; Ottawa, Ontario, Canada.
Victoria T HunnifordClinical Epidemiology Program, The Ottawa Hospital Research Institute; Ottawa, Ontario, Canada.
Kelly D CobeySchool of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Ottawa, Ontario, Canada.
Jamie C BrehautClinical Epidemiology Program, The Ottawa Hospital Research Institute; Ottawa, Ontario, Canada.
Carolina IlkowCancer Therapeutics Program, Ottawa Hospital Research Institute; Ottawa, Ontario, Canada.
Joshua MontroyClinical Epidemiology Program, The Ottawa Hospital Research Institute; Ottawa, Ontario, Canada.
Analyssa CardenasClinical Epidemiology Program, The Ottawa Hospital Research Institute; Ottawa, Ontario, Canada.
Ayni SharifClinical Epidemiology Program, The Ottawa Hospital Research Institute; Ottawa, Ontario, Canada.
Matthew S JeffersClinical Epidemiology Program, The Ottawa Hospital Research Institute; Ottawa, Ontario, Canada.
Dean A FergussonClinical Epidemiology Program, The Ottawa Hospital Research Institute; Ottawa, Ontario, Canada.
Ottawa Hospital · CAUniversity of Ottawa · CAOntario Institute for Cancer Research · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Use of rigorous study design methods and transparent reporting in publications are 2 key strategies proposed to improve the reproducibility of preclinical research. Despite promotion of these practices by funders and journals, assessments suggest uptake is low in preclinical research. Thirty preclinical scientists were interviewed to better understand barriers and enablers to rigorous design and reporting. The interview guide was informed by the Theoretical Domains Framework, which is a framework used to understand determinants of current and desired behavior. Four global themes were identified; 2 reflecting enablers and 2 reflecting barriers. We found that basic scientists are highly motivated to apply the methods of rigorous design and reporting and perceive a number of benefits to their adoption (e.g., improved quality and reliability). However, there was varied awareness of the guidelines and in implementation of these practices. Researchers also noted that these guidelines can result in disadvantages, such as increased sample sizes, expenses, time, and can require several personnel to operationalize. Most researchers expressed additional resources such as personnel and education/training would better enable the application of some methods. Using existing guidance (Behaviour Change Wheel (BCW); Expert Recommendations for Implementing Change (ERIC) project implementation strategies), we mapped and coded our interview findings to identify potential interventions, policies, and implementation strategies to improve routine use of the guidelines by preclinical scientists. These findings will help inform specific strategies that may guide the development of programs and resources to improve experimental design and transparent reporting in preclinical research.

Indexed as

Research DesignQualitative ResearchReproducibility of Results

Identifiers

PMID36603053
PMCPMC9888705
OpenAlexW4313535514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.